QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 4,900.00
+30.00 (0.62%)
At close: Sep 3, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 56.2 billion as of September 4, 2026.
Market Cap
56.20B
Enterprise Value
46.95B
Revenue
7.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,900.00
ChartMarket Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 56.20B, a decrease of -71.89%. That is a compound annual growth rate of -82.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 56.20B | -68.21% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Naturalendo Tech | 69.15B |
| ADBiotech | 67.78B |
| PanGen Biotech | 67.50B |
| Psomagen | 66.17B |
| NovMetaPharma | 62.80B |
| ABION | 60.91B |
| TegoScience | 60.45B |
| KoBioLabs | 56.51B |